nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—head—thyroid cancer	0.0267	0.283	CbGeAlD
Pentosan Polysulfate—FGF1—neck—thyroid cancer	0.0167	0.177	CbGeAlD
Pentosan Polysulfate—FGF2—trachea—thyroid cancer	0.0135	0.143	CbGeAlD
Pentosan Polysulfate—Micturition urgency—Vandetanib—thyroid cancer	0.0109	0.0383	CcSEcCtD
Pentosan Polysulfate—FGF2—thyroid gland—thyroid cancer	0.0107	0.114	CbGeAlD
Pentosan Polysulfate—FGF1—thyroid gland—thyroid cancer	0.00796	0.0844	CbGeAlD
Pentosan Polysulfate—FGF1—head—thyroid cancer	0.00706	0.0749	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—thyroid cancer	0.00665	0.0705	CbGeAlD
Pentosan Polysulfate—Colitis—Vandetanib—thyroid cancer	0.00592	0.0208	CcSEcCtD
Pentosan Polysulfate—FGF1—lymph node—thyroid cancer	0.00494	0.0524	CbGeAlD
Pentosan Polysulfate—Dehydration—Vandetanib—thyroid cancer	0.00416	0.0147	CcSEcCtD
Pentosan Polysulfate—Gastritis—Vandetanib—thyroid cancer	0.00396	0.0139	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Sorafenib—thyroid cancer	0.00376	0.0132	CcSEcCtD
Pentosan Polysulfate—Prothrombin level increased—Epirubicin—thyroid cancer	0.00375	0.0132	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Vandetanib—thyroid cancer	0.00357	0.0126	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Vandetanib—thyroid cancer	0.00353	0.0124	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Vandetanib—thyroid cancer	0.0035	0.0123	CcSEcCtD
Pentosan Polysulfate—Prothrombin level increased—Doxorubicin—thyroid cancer	0.00347	0.0122	CcSEcCtD
Pentosan Polysulfate—Depression—Vandetanib—thyroid cancer	0.00344	0.0121	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Vandetanib—thyroid cancer	0.00336	0.0118	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Vandetanib—thyroid cancer	0.00335	0.0118	CcSEcCtD
Pentosan Polysulfate—Haematuria—Vandetanib—thyroid cancer	0.00329	0.0116	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Vandetanib—thyroid cancer	0.00325	0.0115	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Vandetanib—thyroid cancer	0.00323	0.0114	CcSEcCtD
Pentosan Polysulfate—Mood swings—Sorafenib—thyroid cancer	0.00286	0.0101	CcSEcCtD
Pentosan Polysulfate—Dehydration—Sorafenib—thyroid cancer	0.00281	0.00988	CcSEcCtD
Pentosan Polysulfate—Alopecia—Vandetanib—thyroid cancer	0.00274	0.00963	CcSEcCtD
Pentosan Polysulfate—Gingival bleeding—Epirubicin—thyroid cancer	0.00271	0.00954	CcSEcCtD
Pentosan Polysulfate—Gastritis—Sorafenib—thyroid cancer	0.00267	0.00941	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Epirubicin—thyroid cancer	0.00261	0.0092	CcSEcCtD
Pentosan Polysulfate—Pelvic pain—Epirubicin—thyroid cancer	0.00253	0.00889	CcSEcCtD
Pentosan Polysulfate—Gingival bleeding—Doxorubicin—thyroid cancer	0.00251	0.00882	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Sorafenib—thyroid cancer	0.0025	0.00881	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Epirubicin—thyroid cancer	0.0025	0.0088	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Doxorubicin—thyroid cancer	0.00242	0.00852	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Sorafenib—thyroid cancer	0.00236	0.00831	CcSEcCtD
Pentosan Polysulfate—Pelvic pain—Doxorubicin—thyroid cancer	0.00234	0.00823	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Doxorubicin—thyroid cancer	0.00231	0.00814	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Vandetanib—thyroid cancer	0.00229	0.00808	CcSEcCtD
Pentosan Polysulfate—Jaundice—Sorafenib—thyroid cancer	0.00227	0.00798	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Sorafenib—thyroid cancer	0.00227	0.00798	CcSEcCtD
Pentosan Polysulfate—Oedema—Vandetanib—thyroid cancer	0.0022	0.00774	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Sorafenib—thyroid cancer	0.00219	0.00773	CcSEcCtD
Pentosan Polysulfate—Infection—Vandetanib—thyroid cancer	0.00218	0.00769	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Vandetanib—thyroid cancer	0.00215	0.00758	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Epirubicin—thyroid cancer	0.00215	0.00758	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.002	0.00706	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Doxorubicin—thyroid cancer	0.00199	0.00701	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Epirubicin—thyroid cancer	0.00199	0.00701	CcSEcCtD
Pentosan Polysulfate—Insomnia—Vandetanib—thyroid cancer	0.00199	0.007	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Vandetanib—thyroid cancer	0.00197	0.00695	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Vandetanib—thyroid cancer	0.00196	0.0069	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Sorafenib—thyroid cancer	0.00195	0.00686	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Vandetanib—thyroid cancer	0.00194	0.00682	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vandetanib—thyroid cancer	0.00191	0.00673	CcSEcCtD
Pentosan Polysulfate—Constipation—Vandetanib—thyroid cancer	0.00188	0.00662	CcSEcCtD
Pentosan Polysulfate—Alopecia—Sorafenib—thyroid cancer	0.00184	0.0065	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Doxorubicin—thyroid cancer	0.00184	0.00648	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0018	0.00633	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Epirubicin—thyroid cancer	0.00175	0.00616	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Vandetanib—thyroid cancer	0.00174	0.00612	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Epirubicin—thyroid cancer	0.0017	0.00599	CcSEcCtD
Pentosan Polysulfate—Anaemia—Sorafenib—thyroid cancer	0.00168	0.00592	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Epirubicin—thyroid cancer	0.00167	0.00587	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Sorafenib—thyroid cancer	0.00163	0.00573	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Doxorubicin—thyroid cancer	0.00162	0.0057	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.00157	0.00554	CcSEcCtD
Pentosan Polysulfate—Pruritus—Vandetanib—thyroid cancer	0.00156	0.00548	CcSEcCtD
Pentosan Polysulfate—Myalgia—Sorafenib—thyroid cancer	0.00155	0.00545	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Sorafenib—thyroid cancer	0.00155	0.00545	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Doxorubicin—thyroid cancer	0.00154	0.00543	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Epirubicin—thyroid cancer	0.00154	0.00541	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vandetanib—thyroid cancer	0.0015	0.0053	CcSEcCtD
Pentosan Polysulfate—Colitis—Epirubicin—thyroid cancer	0.00148	0.0052	CcSEcCtD
Pentosan Polysulfate—Infection—Sorafenib—thyroid cancer	0.00147	0.00519	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vandetanib—thyroid cancer	0.00145	0.00512	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Sorafenib—thyroid cancer	0.00145	0.00511	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Epirubicin—thyroid cancer	0.00145	0.00511	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00142	0.00501	CcSEcCtD
Pentosan Polysulfate—Anorexia—Sorafenib—thyroid cancer	0.00141	0.00498	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Epirubicin—thyroid cancer	0.0014	0.00494	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vandetanib—thyroid cancer	0.0014	0.00492	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Epirubicin—thyroid cancer	0.00139	0.00489	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Epirubicin—thyroid cancer	0.00139	0.00489	CcSEcCtD
Pentosan Polysulfate—Rash—Vandetanib—thyroid cancer	0.00139	0.00488	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vandetanib—thyroid cancer	0.00139	0.00488	CcSEcCtD
Pentosan Polysulfate—Headache—Vandetanib—thyroid cancer	0.00138	0.00485	CcSEcCtD
Pentosan Polysulfate—Colitis—Doxorubicin—thyroid cancer	0.00137	0.00481	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00135	0.00476	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Doxorubicin—thyroid cancer	0.00134	0.00473	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Sorafenib—thyroid cancer	0.00132	0.00466	CcSEcCtD
Pentosan Polysulfate—Nausea—Vandetanib—thyroid cancer	0.00131	0.0046	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Sorafenib—thyroid cancer	0.00131	0.0046	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Doxorubicin—thyroid cancer	0.0013	0.00458	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Sorafenib—thyroid cancer	0.00129	0.00454	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Doxorubicin—thyroid cancer	0.00129	0.00453	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Doxorubicin—thyroid cancer	0.00129	0.00453	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Epirubicin—thyroid cancer	0.00127	0.00447	CcSEcCtD
Pentosan Polysulfate—Constipation—Sorafenib—thyroid cancer	0.00127	0.00447	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00121	0.00427	CcSEcCtD
Pentosan Polysulfate—Urticaria—Sorafenib—thyroid cancer	0.00118	0.00415	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—thyroid cancer	0.00118	0.00414	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Sorafenib—thyroid cancer	0.00117	0.00413	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—thyroid cancer	0.0011	0.00387	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Sorafenib—thyroid cancer	0.00109	0.00385	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—thyroid cancer	0.00106	0.00372	CcSEcCtD
Pentosan Polysulfate—Pruritus—Sorafenib—thyroid cancer	0.00105	0.0037	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—thyroid cancer	0.00104	0.00365	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—thyroid cancer	0.00103	0.00363	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—thyroid cancer	0.00102	0.00358	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Sorafenib—thyroid cancer	0.00101	0.00357	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—thyroid cancer	0.000987	0.00348	CcSEcCtD
Pentosan Polysulfate—Dizziness—Sorafenib—thyroid cancer	0.000981	0.00345	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—thyroid cancer	0.000978	0.00344	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—thyroid cancer	0.00096	0.00338	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000953	0.00336	CcSEcCtD
Pentosan Polysulfate—Vomiting—Sorafenib—thyroid cancer	0.000943	0.00332	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—thyroid cancer	0.000939	0.00331	CcSEcCtD
Pentosan Polysulfate—Rash—Sorafenib—thyroid cancer	0.000935	0.00329	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Sorafenib—thyroid cancer	0.000934	0.00329	CcSEcCtD
Pentosan Polysulfate—Headache—Sorafenib—thyroid cancer	0.000929	0.00327	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—thyroid cancer	0.000913	0.00322	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—thyroid cancer	0.000891	0.00314	CcSEcCtD
Pentosan Polysulfate—Nausea—Sorafenib—thyroid cancer	0.000881	0.0031	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00088	0.0031	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—thyroid cancer	0.000877	0.00309	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—thyroid cancer	0.000872	0.00307	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—thyroid cancer	0.000869	0.00306	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—thyroid cancer	0.000838	0.00295	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—thyroid cancer	0.000838	0.00295	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—thyroid cancer	0.000835	0.00294	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—thyroid cancer	0.000824	0.0029	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—thyroid cancer	0.000824	0.0029	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—thyroid cancer	0.00082	0.00289	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000814	0.00287	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—thyroid cancer	0.000812	0.00286	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—thyroid cancer	0.000811	0.00286	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—thyroid cancer	0.000807	0.00284	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—thyroid cancer	0.000806	0.00284	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—thyroid cancer	0.000775	0.00273	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—thyroid cancer	0.000775	0.00273	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—thyroid cancer	0.000774	0.00272	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—thyroid cancer	0.000773	0.00272	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—thyroid cancer	0.000766	0.0027	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—thyroid cancer	0.000762	0.00269	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—thyroid cancer	0.000758	0.00267	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—thyroid cancer	0.00075	0.00264	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—thyroid cancer	0.000746	0.00263	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—thyroid cancer	0.000719	0.00253	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—thyroid cancer	0.000716	0.00252	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—thyroid cancer	0.000709	0.0025	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—thyroid cancer	0.000682	0.0024	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—thyroid cancer	0.000666	0.00234	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—thyroid cancer	0.000662	0.00233	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—thyroid cancer	0.000631	0.00222	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000623	0.00219	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—thyroid cancer	0.000621	0.00219	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—thyroid cancer	0.000617	0.00217	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—thyroid cancer	0.000612	0.00216	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—thyroid cancer	0.000606	0.00213	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—thyroid cancer	0.000601	0.00212	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000577	0.00203	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—thyroid cancer	0.000574	0.00202	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—thyroid cancer	0.000572	0.00201	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—thyroid cancer	0.000572	0.00201	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—thyroid cancer	0.000571	0.00201	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—thyroid cancer	0.000565	0.00199	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—thyroid cancer	0.00056	0.00197	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—thyroid cancer	0.000556	0.00196	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—thyroid cancer	0.000548	0.00193	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—thyroid cancer	0.000545	0.00192	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—thyroid cancer	0.000537	0.00189	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—thyroid cancer	0.00053	0.00187	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—thyroid cancer	0.000529	0.00186	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—thyroid cancer	0.000529	0.00186	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—thyroid cancer	0.000523	0.00184	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—thyroid cancer	0.000523	0.00184	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—thyroid cancer	0.000507	0.00179	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—thyroid cancer	0.000504	0.00177	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000499	0.00176	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000497	0.00175	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—thyroid cancer	0.000496	0.00175	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—thyroid cancer	0.000492	0.00173	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00049	0.00173	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—thyroid cancer	0.000489	0.00172	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—thyroid cancer	0.000484	0.0017	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—thyroid cancer	0.000483	0.0017	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—thyroid cancer	0.000477	0.00168	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—thyroid cancer	0.000469	0.00165	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000462	0.00163	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—thyroid cancer	0.000459	0.00162	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—thyroid cancer	0.000455	0.0016	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—thyroid cancer	0.000452	0.00159	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—thyroid cancer	0.000452	0.00159	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000448	0.00158	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—thyroid cancer	0.000446	0.00157	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—thyroid cancer	0.000441	0.00155	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—thyroid cancer	0.000436	0.00153	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—thyroid cancer	0.000434	0.00153	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—thyroid cancer	0.000433	0.00153	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000418	0.00147	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000415	0.00146	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—thyroid cancer	0.000404	0.00142	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—thyroid cancer	0.000403	0.00142	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—thyroid cancer	0.000401	0.00141	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—thyroid cancer	0.000388	0.00137	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—thyroid cancer	0.000375	0.00132	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000374	0.00132	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—thyroid cancer	0.000363	0.00128	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—thyroid cancer	0.000359	0.00126	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—thyroid cancer	0.000349	0.00123	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—thyroid cancer	0.000347	0.00122	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—thyroid cancer	0.000346	0.00122	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—thyroid cancer	0.000345	0.00122	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—thyroid cancer	0.000343	0.00121	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—thyroid cancer	0.000335	0.00118	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—thyroid cancer	0.000326	0.00115	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—thyroid cancer	0.000323	0.00114	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—thyroid cancer	0.00032	0.00113	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—thyroid cancer	0.00032	0.00113	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—thyroid cancer	0.000318	0.00112	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—thyroid cancer	0.000301	0.00106	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by FGFR—KRAS—thyroid cancer	0.000287	0.000462	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—LGALS3—thyroid cancer	0.000287	0.000461	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—KRAS—thyroid cancer	0.000287	0.000461	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—HRAS—thyroid cancer	0.000286	0.00046	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—KRAS—thyroid cancer	0.000286	0.000459	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PRKAR1A—thyroid cancer	0.000284	0.000458	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NRG1—thyroid cancer	0.000284	0.000457	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—KRAS—thyroid cancer	0.000284	0.000457	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—HRAS—thyroid cancer	0.000281	0.000453	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TCF7L1—thyroid cancer	0.00028	0.000451	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—KRAS—thyroid cancer	0.00028	0.00045	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000276	0.000444	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MEN1—thyroid cancer	0.000275	0.000443	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	0.000275	0.000442	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTCH1—thyroid cancer	0.000275	0.000442	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—HRAS—thyroid cancer	0.000273	0.000438	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NRG1—thyroid cancer	0.000272	0.000437	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—KRAS—thyroid cancer	0.000271	0.000436	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NRG1—thyroid cancer	0.00027	0.000434	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—HRAS—thyroid cancer	0.000269	0.000432	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—HRAS—thyroid cancer	0.000267	0.00043	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—HRAS—thyroid cancer	0.000267	0.00043	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—KRAS—thyroid cancer	0.000267	0.00043	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—KRAS—thyroid cancer	0.000267	0.00043	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—KRAS—thyroid cancer	0.000267	0.00043	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TPR—thyroid cancer	0.000267	0.000429	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—HRAS—thyroid cancer	0.000266	0.000428	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—KRAS—thyroid cancer	0.000265	0.000426	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—HRAS—thyroid cancer	0.000265	0.000426	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—AKT1—thyroid cancer	0.000264	0.000424	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PRKAR1A—thyroid cancer	0.000263	0.000422	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—KRAS—thyroid cancer	0.000263	0.000422	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—KRAS—thyroid cancer	0.000261	0.00042	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	0.000261	0.00042	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—HRAS—thyroid cancer	0.000261	0.000419	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—PTEN—thyroid cancer	0.00026	0.000418	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	0.00026	0.000418	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NRG1—thyroid cancer	0.000259	0.000417	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—HRAS—thyroid cancer	0.000257	0.000413	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TCF7L1—thyroid cancer	0.000255	0.000411	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—AKT1—thyroid cancer	0.000253	0.000406	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000252	0.000405	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SST—thyroid cancer	0.000251	0.000404	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MEN1—thyroid cancer	0.000251	0.000404	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NRG1—thyroid cancer	0.000251	0.000404	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—HRAS—thyroid cancer	0.000249	0.000401	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—HRAS—thyroid cancer	0.000249	0.000401	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	0.000249	0.000401	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—AKT1—thyroid cancer	0.000249	0.0004	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—KRAS—thyroid cancer	0.000247	0.000398	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—HRAS—thyroid cancer	0.000247	0.000397	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000245	0.000394	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—HRAS—thyroid cancer	0.000245	0.000394	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—HRAS—thyroid cancer	0.000245	0.000394	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—HRAS—thyroid cancer	0.000244	0.000392	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—HRAS—thyroid cancer	0.000244	0.000392	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—HRAS—thyroid cancer	0.000243	0.00039	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CALCA—thyroid cancer	0.000242	0.000389	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—HRAS—thyroid cancer	0.000242	0.000388	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—AKT1—thyroid cancer	0.000241	0.000387	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	0.000238	0.000383	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—AKT1—thyroid cancer	0.000237	0.000382	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—PTEN—thyroid cancer	0.000237	0.000381	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	0.000237	0.000381	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—AKT1—thyroid cancer	0.000236	0.00038	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—AKT1—thyroid cancer	0.000236	0.00038	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—AKT1—thyroid cancer	0.000235	0.000378	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—AKT1—thyroid cancer	0.000234	0.000376	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—PTEN—thyroid cancer	0.000234	0.000376	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—NRAS—thyroid cancer	0.000232	0.000373	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—HRAS—thyroid cancer	0.000231	0.000371	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	0.00023	0.000371	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—AKT1—thyroid cancer	0.00023	0.00037	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—HRAS—thyroid cancer	0.000227	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—HRAS—thyroid cancer	0.000227	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	0.000227	0.000365	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—AKT1—thyroid cancer	0.000227	0.000364	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TERT—thyroid cancer	0.000225	0.000362	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—HRAS—thyroid cancer	0.000225	0.000362	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—PTEN—thyroid cancer	0.000224	0.000361	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000224	0.00036	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—PPARG—thyroid cancer	0.000223	0.000359	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—HRAS—thyroid cancer	0.000223	0.000359	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—HRAS—thyroid cancer	0.000222	0.000357	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	0.000221	0.000355	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	0.00022	0.000354	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—AKT1—thyroid cancer	0.00022	0.000354	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—AKT1—thyroid cancer	0.00022	0.000354	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CALCA—thyroid cancer	0.000219	0.000353	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDK1—thyroid cancer	0.000219	0.000352	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—AKT1—thyroid cancer	0.000218	0.000351	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—AKT1—thyroid cancer	0.000216	0.000348	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—AKT1—thyroid cancer	0.000216	0.000348	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HIF1A—thyroid cancer	0.000215	0.000346	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—AKT1—thyroid cancer	0.000215	0.000346	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—AKT1—thyroid cancer	0.000215	0.000346	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDK1—thyroid cancer	0.000215	0.000346	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—AKT1—thyroid cancer	0.000214	0.000345	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—AKT1—thyroid cancer	0.000213	0.000343	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—NRAS—thyroid cancer	0.000212	0.00034	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—HRAS—thyroid cancer	0.00021	0.000338	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	0.00021	0.000338	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—NRAS—thyroid cancer	0.000208	0.000335	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000207	0.000333	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFNA2—thyroid cancer	0.000207	0.000332	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TSHR—thyroid cancer	0.000205	0.00033	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—AKT1—thyroid cancer	0.000204	0.000327	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000202	0.000324	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	0.000201	0.000324	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—AKT1—thyroid cancer	0.000201	0.000323	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—AKT1—thyroid cancer	0.000201	0.000323	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	0.000201	0.000323	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—NRAS—thyroid cancer	0.0002	0.000322	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CALCA—thyroid cancer	0.0002	0.000321	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—KRAS—thyroid cancer	0.0002	0.000321	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—AKT1—thyroid cancer	0.000199	0.00032	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDK1—thyroid cancer	0.000198	0.000319	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—AKT1—thyroid cancer	0.000197	0.000317	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—AKT1—thyroid cancer	0.000196	0.000316	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDK1—thyroid cancer	0.000196	0.000315	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	0.000195	0.000313	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MEN1—thyroid cancer	0.000193	0.00031	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000189	0.000304	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNA2—thyroid cancer	0.000188	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TSHR—thyroid cancer	0.000187	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—AKT1—thyroid cancer	0.000186	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000184	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—KRAS—thyroid cancer	0.000182	0.000293	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDK1—thyroid cancer	0.000181	0.000291	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—KRAS—thyroid cancer	0.000179	0.000289	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—BRAF—thyroid cancer	0.000178	0.000287	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	0.000178	0.000286	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MEN1—thyroid cancer	0.000176	0.000283	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRG1—thyroid cancer	0.000176	0.000283	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTCH1—thyroid cancer	0.000174	0.00028	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRG1—thyroid cancer	0.000172	0.000277	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KRAS—thyroid cancer	0.000172	0.000277	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—HRAS—thyroid cancer	0.00017	0.000273	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SST—thyroid cancer	0.000159	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRG1—thyroid cancer	0.000159	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTCH1—thyroid cancer	0.000159	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TERT—thyroid cancer	0.000158	0.000254	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRG1—thyroid cancer	0.000157	0.000253	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—HRAS—thyroid cancer	0.000155	0.000249	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CALCA—thyroid cancer	0.000153	0.000247	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—HRAS—thyroid cancer	0.000153	0.000245	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HIF1A—thyroid cancer	0.000151	0.000243	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—AKT1—thyroid cancer	0.00015	0.000241	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PTEN—thyroid cancer	0.000148	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HRAS—thyroid cancer	0.000146	0.000236	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SST—thyroid cancer	0.000145	0.000234	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRG1—thyroid cancer	0.000145	0.000234	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—thyroid cancer	0.000144	0.000232	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TERT—thyroid cancer	0.000143	0.00023	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PTEN—thyroid cancer	0.000142	0.000229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CALCA—thyroid cancer	0.00014	0.000225	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDK1—thyroid cancer	0.000139	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HIF1A—thyroid cancer	0.000137	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—thyroid cancer	0.000137	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NRAS—thyroid cancer	0.000137	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PTEN—thyroid cancer	0.000136	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PTEN—thyroid cancer	0.000135	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—thyroid cancer	0.000135	0.000217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NRAS—thyroid cancer	0.000132	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TERT—thyroid cancer	0.00013	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PTEN—thyroid cancer	0.00013	0.000209	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—thyroid cancer	0.000129	0.000208	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NRAS—thyroid cancer	0.000127	0.000204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDK1—thyroid cancer	0.000127	0.000204	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTEN—thyroid cancer	0.000126	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—BRAF—thyroid cancer	0.000125	0.000201	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HIF1A—thyroid cancer	0.000125	0.000201	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NRAS—thyroid cancer	0.000121	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NRAS—thyroid cancer	0.000121	0.000194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—thyroid cancer	0.000118	0.000189	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NRAS—thyroid cancer	0.000116	0.000186	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—thyroid cancer	0.000114	0.000183	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—BRAF—thyroid cancer	0.000113	0.000182	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NRAS—thyroid cancer	0.000112	0.00018	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRG1—thyroid cancer	0.000112	0.000179	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—thyroid cancer	0.000109	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—thyroid cancer	0.000105	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—thyroid cancer	0.000104	0.000167	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—thyroid cancer	0.000103	0.000166	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRG1—thyroid cancer	0.000102	0.000164	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—thyroid cancer	0.0001	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—thyroid cancer	0.0001	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—thyroid cancer	9.97e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—thyroid cancer	9.68e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—thyroid cancer	9.65e-05	0.000155	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HIF1A—thyroid cancer	9.58e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—thyroid cancer	9.3e-05	0.00015	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—thyroid cancer	9.15e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—thyroid cancer	9.13e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—thyroid cancer	9.12e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—thyroid cancer	8.88e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—thyroid cancer	8.83e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—thyroid cancer	8.83e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—thyroid cancer	8.8e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HIF1A—thyroid cancer	8.73e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—thyroid cancer	8.64e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—thyroid cancer	8.55e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—thyroid cancer	8.48e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—thyroid cancer	8.34e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—thyroid cancer	8.21e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—thyroid cancer	8.2e-05	0.000132	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—thyroid cancer	7.98e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—thyroid cancer	7.93e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—thyroid cancer	7.88e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—thyroid cancer	7.85e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—thyroid cancer	7.84e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—thyroid cancer	7.8e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—thyroid cancer	7.71e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—thyroid cancer	7.49e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—thyroid cancer	7.27e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—thyroid cancer	7.24e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—thyroid cancer	7.23e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—thyroid cancer	7.12e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—thyroid cancer	7.03e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—thyroid cancer	6.76e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—thyroid cancer	6.63e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—thyroid cancer	6.49e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—thyroid cancer	6.12e-05	9.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—thyroid cancer	6.05e-05	9.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—thyroid cancer	6.01e-05	9.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—thyroid cancer	5.79e-05	9.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—thyroid cancer	5.74e-05	9.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—thyroid cancer	5.64e-05	9.07e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—thyroid cancer	5.59e-05	8.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—thyroid cancer	5.59e-05	8.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—thyroid cancer	5.28e-05	8.49e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—thyroid cancer	5.21e-05	8.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—thyroid cancer	5.14e-05	8.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—thyroid cancer	5.09e-05	8.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—thyroid cancer	5.07e-05	8.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—thyroid cancer	4.98e-05	8.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—thyroid cancer	4.98e-05	8.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—thyroid cancer	4.75e-05	7.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—thyroid cancer	4.6e-05	7.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—thyroid cancer	4.54e-05	7.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—thyroid cancer	4.54e-05	7.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—thyroid cancer	4.29e-05	6.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—thyroid cancer	4.19e-05	6.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—thyroid cancer	3.91e-05	6.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—thyroid cancer	3.81e-05	6.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—thyroid cancer	3.65e-05	5.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—thyroid cancer	3.48e-05	5.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—thyroid cancer	3.32e-05	5.35e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—thyroid cancer	3.22e-05	5.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—thyroid cancer	2.94e-05	4.72e-05	CbGpPWpGaD
